Please download the dossier by clicking on the dossier button x
×

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

  • US 10,000,523 B2
  • Filed: 10/12/2017
  • Issued: 06/19/2018
  • Est. Priority Date: 03/06/2015
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising an anti-HCV effective amount of a compound of the formula:

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×